Sierra Oncology Company Profile (NASDAQ:DNAI)

About Sierra Oncology (NASDAQ:DNAI)

Sierra Oncology logoSierra Oncology, Inc., formerly ProNAi Therapeutics, Inc., is a clinical-stage drug development company. The Company's lead drug candidate, SRA737, is orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1), a key cell cycle checkpoint and central regulator of the deoxyribonucleic acid (DNA) Damage Response (DDR) network. SRA737 is being investigated in approximately two Phase I clinical trials in patients with advanced cancer. Sierra Oncology is also advancing SRA141, an orally bioavailable small molecule inhibitor of the cell division cycle 7 kinase (Cdc7) kinase undergoing preclinical development. Sierra is building a range of pipeline of various oncology assets against targets at the edge of cancer biology. The Company's SRA737 and SRA141 target the DDR network, a scientifically approach with far-reaching potential across oncology. SRA141 is an orally available small molecule inhibitor of Cdc7.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:DNAI
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $1.48
  • 200 Day Moving Avg: $1.72
  • 52 Week Range: $1.32 - $10.37
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.33
  • P/E Growth: 0.00
Misc:
  • Average Volume: 556,061 shs.
 

Frequently Asked Questions for Sierra Oncology (NASDAQ:DNAI)

What is Sierra Oncology's stock symbol?

Sierra Oncology trades on the NASDAQ under the ticker symbol "DNAI."

Where is Sierra Oncology's stock going? Where will Sierra Oncology's stock price be in 2017?

1 brokerages have issued 1 year price objectives for Sierra Oncology's shares. Their predictions range from $4.00 to $4.00. On average, they anticipate Sierra Oncology's share price to reach $4.00 in the next year. View Analyst Ratings for Sierra Oncology.

Who are some of Sierra Oncology's key competitors?

When did Sierra Oncology IPO?

(DNAI) raised $100 million in an IPO on Thursday, July 16th 2015. The company issued 6,700,000 shares at $14.00-$16.00 per share. Jefferies and BofA Merrill Lynch served as the underwriters for the IPO and Wedbush PacGrow and SunTrust Robinson Humphrey were co-managers.

How do I buy Sierra Oncology stock?

Shares of Sierra Oncology can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Sierra Oncology stock cost?

One share of Sierra Oncology stock can currently be purchased for approximately $1.56.

Analyst Ratings

Consensus Ratings for Sierra Oncology (NASDAQ:DNAI) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.00 (156.41% upside)

Analysts' Ratings History for Sierra Oncology (NASDAQ:DNAI)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/6/2017WedbushReiterated RatingOutperform$4.00N/AView Rating Details
(Data available from 5/28/2015 forward)

Earnings

Earnings History for Sierra Oncology (NASDAQ:DNAI)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Sierra Oncology (NASDAQ:DNAI)
Current Year EPS Consensus Estimate: $-1.55 EPS
Next Year EPS Consensus Estimate: $-1.17 EPS

Dividends

Dividend History for Sierra Oncology (NASDAQ:DNAI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sierra Oncology (NASDAQ:DNAI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Sierra Oncology (NASDAQ:DNAI)
Latest Headlines for Sierra Oncology (NASDAQ:DNAI)
Source:
DateHeadline
americanbankingnews.com logoSierra Oncology (DNAI) Earns News Sentiment Score of 0.08
www.americanbankingnews.com - April 23 at 6:34 PM
biz.yahoo.com logoSIERRA ONCOLOGY, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Even
biz.yahoo.com - January 11 at 5:16 PM
us.rd.yahoo.com logoFINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ProNAi Therapeutics, Inc. (DNAI) and Lead Plaintiff Deadline - January 9, 2017
us.rd.yahoo.com - January 9 at 4:37 PM
finance.yahoo.com logoDNAI DEADLINE ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017
finance.yahoo.com - January 6 at 5:14 PM
finance.yahoo.com logoEQUITY ALERT: Khang & Khang LLP Announces an Investigation of ProNAi Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - January 6 at 5:14 PM
finance.yahoo.com logoDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ProNAi Therapeutics, Inc. (DNAI) and Lead Plaintiff Deadline - January 9, 2017
finance.yahoo.com - January 5 at 5:35 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action Lawsuit Against ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017 – DNAI
us.rd.yahoo.com - January 4 at 5:49 PM
businesswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Commencement of a Class Action Lawsuit Against ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January ...
www.businesswire.com - December 30 at 1:42 AM
finance.yahoo.com logoDEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ProNAi Therapeutics, Inc. (DNAI) and Lead Plaintiff Deadline - January 9, 2017
finance.yahoo.com - December 29 at 3:38 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Commencement of a Class Action Lawsuit Against ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017
finance.yahoo.com - December 29 at 3:38 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ProNAi Therapeutics, Inc. (DNAI) and Lead Plaintiff Deadline - January 9, 2017
us.rd.yahoo.com - December 22 at 10:00 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of ProNAi Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - December 22 at 4:59 PM
businesswire.com logoDNAI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class ... - Business Wire (press release)
www.businesswire.com - December 22 at 3:35 AM
businesswire.com logoDNAI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of ...
www.businesswire.com - December 21 at 5:34 PM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces an Investigation of ProNAi Therapeutics Inc and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - December 21 at 5:34 PM
finance.yahoo.com logoDNAI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017
finance.yahoo.com - December 21 at 10:33 AM
benzinga.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang...
www.benzinga.com - December 18 at 3:02 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of ProNAi Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - December 17 at 3:19 AM
finance.yahoo.com logoDNAI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ProNAi …
finance.yahoo.com - December 16 at 5:15 PM
finance.yahoo.com logoDNAI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017
finance.yahoo.com - December 16 at 5:15 PM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ProNAi Therapeutics, Inc. (DNAI) and Lead Plaintiff Deadline: January 9, 2017
finance.yahoo.com - December 15 at 5:18 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of ProNAi Therapeutics Inc and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - December 15 at 5:18 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of ProNAi Therapeutics Inc. and Advises Investors with Losses to Contact the Firm
finance.yahoo.com - December 14 at 5:48 PM
finance.yahoo.com logoCohen Milstein Sellers & Toll PLLC Announces Investigation of ProNAi Therapeutics Inc.
finance.yahoo.com - December 13 at 5:25 PM
finance.yahoo.com logoScott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers …
finance.yahoo.com - December 12 at 5:01 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Commencement of a Class Action Lawsuit Against ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017
finance.yahoo.com - December 12 at 12:02 PM
finance.yahoo.com logoScott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in ProNAi Therapeutics, Inc. (NASDAQ: DNAI) Securities Case
finance.yahoo.com - December 12 at 12:02 PM
finance.yahoo.com logoRobbins Arroyo LLP: ProNAi Therapeutics, Inc. (DNAI) Misled Shareholders According to a Recently Filed Class Action
finance.yahoo.com - December 9 at 5:04 PM

Social

Chart

Sierra Oncology (DNAI) Chart for Sunday, May, 28, 2017

This page was last updated on 5/28/2017 by MarketBeat.com Staff